To answer TomTeleRx's question specifically:
From a clinical standpoint, Hypoglycemia risk with is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
Following this thread closely. Hypoglycemia risk with is something I'm actively working through.
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Hypoglycemia risk with.
To answer mike.trainer_LA: yes, I am on compounded sema from a 503B pharmacy.
Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSubscribing to this thread. Hypoglycemia risk with is exactly what I've been researching. 🙏
CarlaRPh_TPA said:The Hypoglycemia risk discussion here is so valuable
This is exactly right. CarlaRPh_TPA articulated what I have been trying to explain to my friends for months. The Hypoglycemia risk with aspect is what made the difference for me.